Caris Life Sciences, Inc.
CAI
Rankning i aktier
#2256
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing... Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
Aktiekurs
$31.17
Marknadsvärde
$8.81B
Förändring (1 dag)
-3.66%
Förändring (1 år)
3.75%
Land
US
Handel Caris Life Sciences, Inc. (CAI)
Kategori
Healthcare
Aktiekurshistorik för Caris Life Sciences, Inc. (CAI)
Högsta slutkurs: $29.75 den 2026-10-01
Lägsta slutkurs: $26.95 den 2025-06-01
Lägsta slutkurs: $26.95 den 2025-06-01
Aktiekurshistorik för Caris Life Sciences, Inc. från 2025 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2026 (TTM) | -17.62% |
| 2025 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $535.96 | 25.68% |
US
|
|
| $186.23 | 593.59% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $892.29 | 9.59% |
NL
|
